Gilead is in the hot seat again. Tuesday, the University of Minnesota filed in federal court defending the patent rights allegedly secured and assigned to the school by Dr. Carston Wagner, an endowed chair in medicinal chemistry at the School of Pharmacy. (The U of M, by the way, was ranked the second best pharmacy school in the nation. Go Gophers!) The drugs covered by patent, the U says—“antiviral compounds and methods for using those compounds to treat viral infections, such as that caused by hepatitis C virus”—include those that contain products that contain the drug sofosbuvir.
Here are few other stories we came across this week that you might find interesting: